Does Mitochondrial Dysfunction Drive Immune Privilege Collapse in Lichen Planopilaris Pathogenesis?

    Jonathan A. Hardman, Sreejith Parameswara Panicker, Matthew Harries, Ralf Paus
    Image of study
    TLDR Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.
    The study explored the role of mitochondrial dysfunction in the development of Lichen planopilaris (LPP), a form of scarring alopecia. It found that Mitochondrial transcription factor A was down-regulated in LPP hair follicles, while functional markers MT-CO1 and VDAC1 were upregulated, suggesting that mitochondria were overactive despite issues with genome replication. These findings indicate that a metabolic switch to mitochondrial respiration in LPP may lead to chronic inflammation and loss of immune privilege, potentially due to excess ATP production and the release of damage-associated molecular patterns. This points to mitochondrial dysfunction as a possible underlying mechanism in LPP and potentially other autoimmune diseases. The exact number of samples analyzed was not mentioned.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 37 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 2 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 2 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 8 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Clascoterone (Winlevi) Update for Canada

      in Treatment  16 upvotes 2 years ago
      Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hair loss treatment.

    Related Research

    1 / 1 results